Day: March 15, 2022

Why Crypto Hackers Always End Up Getting Caught Out

by
Published by
ValueWalk

Since the earliest days of crypto, hackers have been one of the biggest threats to the space. As the markets have grown, cryptocurrency security has become one of the most significant sources of unease for investors. Following several high-profile thefts on exchanges like Bitfinex and Mt.Gox, the popular wisdom in the crypto space was that you should store funds on a non-custodial wallet. But even they aren’t necessarily safe. If white hat hackers can penetrate a hardware wallet to restore lost crypto, then you can bet that a black-hat hacker would be ready to exploit the same weaknesses. Q4 2…

Read more

Neeyamo’s SuccessIN – Now Available on SAP® Store

by

By integrating with the SAP® SuccessFactors® Employee Central solution, Neeyamo’s global payroll connector helps global organizations experience a streamlined, integrated HR and global payroll solution suite LOS GATOS, Calif., March 15, 2022 (GLOBE NEWSWIRE) — Neeyamo Enterprise Solutions today announced that its global payroll connector SuccessIN is now available on SAP® Store, the online marketplace […]

Flight Centre increases its equity stake in TPConnects Technologies, a Dubai-Based Travel Tech Company

by

Rajendran Vellapalath DUBAI, Arab Emirates, March 15, 2022 (GLOBE NEWSWIRE) — The Flight Centre Travel Group (FLT) has reinforced its commitment to providing customers with the widest choice of airfares by increasing its investment in travel technology business TPConnects Technologies (TPC). The company has agreed to increase its equity stake from 22.5% to 70% in […]

Junshi Biosciences and Coherus Announce Presentation of Positive Results from CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer, at March ASCO Plenary Series

by

– Toripalimab plus chemotherapy met both primary endpoint of progression free survival and prespecified secondary endpoint of overall survival compared to chemotherapy alone – – Data support the use of toripalimab with chemotherapy as first-line treatment for advanced NSCLC patients without EGFR/ALK mutations – SHANGHAI, China and REDWOOD CITY, Calif., March 15, 2022 (GLOBE NEWSWIRE) — […]

Prevasio Announces Oscar Marquez as New CEO

by

Expansion of management team strengthens leadership, prepares company for further success MENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) — Prevasio, Inc., a startup providing next-generation tools to democratize Cloud Security Posture Management, announces that Oscar Marquez will be joining the company as CEO. In his new role, Oscar will be spearheading the expansion of […]

Former ProcessGold CEO Erik-Jan van der Linden Joins mindzie as a Strategic Advisor

by

~Renowned business leader to help guide European expansion strategy as mindzie emerges as a global leader in process mining and optimization~ Process Map DALLAS, March 15, 2022 (GLOBE NEWSWIRE) — mindzie, inc. (“mindzie“), provider of process mining and business process optimization software, today announced that Erik-Jan van der Linden, former Chief Executive Officer of ProcessGold, […]

Latest release of Philips Capsule Surveillance receives FDA clearance

by

March 15, 2022 Clinical surveillance solution is designed to identify emergent patient deterioration and offer enhanced patient data visibility, flexible viewing options, and clinical decision support Facilitates remote patient oversight at mobile, eICU and virtual care clinical touchpoints New FDA clearance covers additional use cases and information access methods Amsterdam, the Netherlands – Royal Philips […]

First Participants Dosed in Phase 2a Study of Pan-Antiviral Nasal Spray

by

ENA Respiratory begins influenza challenge study for fast-acting nasal spray INNA-051, designed to boost innate immunity in patients at high risk of severe complications from respiratory infections SYDNEY, Australia, March 15, 2022 (GLOBE NEWSWIRE) —  ENA Respiratory, a clinical-stage pharmaceutical company developing INNA-051, a first-in-class broad-spectrum antiviral innate immunomodulator for pre- and post-exposure prophylaxis of […]